Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

Sat, 16.05.2026       Daiichi Sankyo
JP3475350009

Enhertu® (fam-trastuzumab deruxtecan-nxki) has been approved by the U.S. Food and Drug Administration (FDA) for two new breast cancer indications in the neoadjuvant and adjuvant settings of patients with HER2 positive early breast cancer. In the neoadjuvant setting, Enhertu followed by a taxane, trastuzumab and pertuzumab (THP) has been approved...
Read more
Daiichi Sankyo
Technical Analysis Termsheets Terminal
Permalink